LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

M 3 muscarinic acetylcholine receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

M-4 and iso M-4 derivatives, their preparation and compositions

Drug – bio-affecting and body treating compositions – Nonspecific immunoeffector – per se ; or nonspecific... – Synthetic or structurally-modified peptidoglycan or...

M-4 And IsoM-4 derivatives and compositions containing them

Drug – bio-affecting and body treating compositions – Nonspecific immunoeffector – per se ; or nonspecific... – Synthetic or structurally-modified peptidoglycan or...

M-4 and IsoM-4 derivatives their preparation and compositions co

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

M-4 and IsoM-4 derivatives, their preparation and compositions c

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

m-Amino-phenylimino-imidazolidine derivatives for treating...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

m-Amino-phenylimino-imidazolidine derivatives for treating...

Drug – bio-affecting and body treating compositions – Lymphokine

M-CSF as a therapeutic agent for thrombocytopenia

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...

M-EDTA pharmaceutical preparations and uses thereof

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...

M-phenoxybenzyl and .alpha.-cyano-M-phenoxybenzyl esters of 2-ha

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...

M-Phenylene dioxamic acid derivatives

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof

M-protein peptides of influenza virus as antiviral agents

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

M-Trifluoro-methylphenyl-piperazine

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Fungus – except allergen – or component thereof or substance...

M. canis -containing ringworm vaccine

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Fungus – except allergen – or component thereof or substance...

M. canis containing ringworm vaccine

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...

M. catarrhalis outer membrane protein-106 polypeptide,...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

M. haemolytica outer membrane protein P1pE as a vaccine or...

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

M. tuberculosis antigens

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

M.sub.2 receptor ligand for the treatment of neurological disord